Intercept Pharmaceuticals Company
Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.
Headquarters:
United States
Employee Number:
501-1000
Founded Date:
2002
Technology:
Cancer
Estimated Revenue:
$50M to $100M
Industry:
Metabolism Dysfunctions
Funding Status:
IPO